Bayer Q1 earnings: 2,000 jobs cut as it homes in on year-end rehaul targetnews2025-05-13T10:37:46+00:00May 13th, 2025|Endpoints News|
Pharma investors brush off Trump’s ‘most favored nation’ plan as stocks risenews2025-05-12T19:35:04+00:00May 12th, 2025|Endpoints News|
Trump’s drug price plan is light on details, may have little impactnews2025-05-12T19:31:11+00:00May 12th, 2025|Endpoints News|
Republican tax cut bill includes PBM, drug price negotiation changesnews2025-05-12T17:18:52+00:00May 12th, 2025|Endpoints News|
Roche could rethink $50B US expansion plan if new policies ‘harm’ operationsnews2025-05-12T17:09:47+00:00May 12th, 2025|Endpoints News|
Trump signs ‘most favored nation’ order to try to lower US drug pricesnews2025-05-12T13:11:02+00:00May 12th, 2025|Endpoints News|
Trump confirms ‘most favored nation’ drug price plansnews2025-05-12T01:51:50+00:00May 12th, 2025|Endpoints News|
Iovance stock plummets after lowered full-year guidancenews2025-05-09T18:31:52+00:00May 9th, 2025|Endpoints News|
Lonza says its US-based sites are in high demand as pharma tariffs nearnews2025-05-09T14:17:22+00:00May 9th, 2025|Endpoints News|
Illumina confirms SEC has closed investigation into $8B Grail dealnews2025-05-08T22:32:18+00:00May 8th, 2025|Endpoints News|
